<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36649137</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Print">0032-5422</ISSN><JournalIssue CitedMedium="Print"><Volume>68</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Postepy biochemii</Title><ISOAbbreviation>Postepy Biochem</ISOAbbreviation></Journal><ArticleTitle>[The role of steroid hormones in the neurodegenerative diseases].</ArticleTitle><Pagination><StartPage>387</StartPage><EndPage>398</EndPage><MedlinePgn>387-398</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18388/pb.2021_468</ELocationID><Abstract><AbstractText>An increasing number of elders in a general population and longer life expectancy have a negative outcome in the growth of dissemination of neurodegenerative diseases (NDs). The NDs like Alzheimer&#x2019;s disease (AD), Parkinson&#x2019;s disease (PD) and amyotrophic lateral sclerosis (ALS) show sex-dependent prevalence. It is considered that sex steroids could influence on the NDs occurrence. Epidemiological studies indicate that women suffer more frequently from AD, whereas men from PD and ALS. Research suggest neuroprotective effects of estrogens and confirm that factors reducing their level may have a contribution to a higher morbidity rate to NDs. Adverse effects of androgens on NDs have been noticed, however some data suggest their beneficial actions. Therefore, the understanding of the potential role of sex steroids and their receptors in the pathogenesis and course of NDs would contribute to broadening the knowledge of molecular mechanisms leading to NDs. Moreover effective prevention and treatment could be assessed in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadowska</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Zak&#x142;ad Endokrynologii, Instytut Zoologii i Bada&#x144; Biomedycznych, Wydzia&#x142; Biologii, Uniwersytet Jagiello&#x144;ski w Krakowie. aleksa.sadowska@student.uj.edu.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grzesiak</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Uniwersytet Jagiello&#x144;ski w Krakowie. m.e.grzesiak@uj.edu.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>pol</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Rola steroid&#xf3;w p&#x142;ciowych w chorobach neurodegeneracyjnych.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Postepy Biochem</MedlineTA><NlmUniqueID>0023525</NlmUniqueID><ISSNLinking>0032-5422</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013256">Steroids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006728">Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013256" MajorTopicYN="N">Steroids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006728" MajorTopicYN="N">Hormones</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="pol"><AbstractText>Wraz ze wzrostem &#x15b;redniej d&#x142;ugo&#x15b;ci &#x17c;ycia i starzeniem si&#x119; ludzkiej populacji, zwi&#x119;ksza si&#x119; odsetek os&#xf3;b cierpi&#x105;cych na choroby neurodegeneracyjne (NDs). W przypadku choroby Alzheimera (AD), choroby Parkinsona (PD) i stwardnienia zanikowego bocznego (ALS), zaobserwowano wyra&#x17a;n&#x105; dysproporcj&#x119; w zachorowalno&#x15b;ci w zale&#x17c;no&#x15b;ci od p&#x142;ci. Uwa&#x17c;a si&#x119;, &#x17c;e mo&#x17c;e to mie&#x107; zwi&#x105;zek z wp&#x142;ywem steroid&#xf3;w p&#x142;ciowych na ryzyko wyst&#x105;pienia tych chor&#xf3;b. Dane epidemiologiczne pokazuj&#x105;, &#x17c;e na AD cz&#x119;&#x15b;ciej cierpi&#x105; kobiety, natomiast PD i ALS s&#x105; bardziej rozpowszechnione u m&#x119;&#x17c;czyzn. Liczne badania wskazuj&#x105; na neuroprotekcyjne dzia&#x142;anie estrogen&#xf3;w i potwierdzaj&#x105;, &#x17c;e czynniki redukuj&#x105;ce ich poziom zwi&#x119;kszaj&#x105; ryzyko zachorowania na NDs. Odwrotne efekty zaobserwowano dla androgen&#xf3;w, chocia&#x17c; dowiedziono tak&#x17c;e korzystnego wp&#x142;ywu tych hormon&#xf3;w. Zrozumienie potencjalnej roli steroid&#xf3;w p&#x142;ciowych i ich receptor&#xf3;w w patogenezie i przebiegu NDs mo&#x17c;e przyczyni&#x107; si&#x119; do lepszego poznania molekularnych mechanizm&#xf3;w le&#x17c;&#x105;cych u pod&#x142;o&#x17c;a tych schorze&#x144;, a tym samym do opracowania skuteczniejszych sposob&#xf3;w prewencji i leczenia.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36649137</ArticleId><ArticleId IdType="doi">10.18388/pb.2021_468</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>